CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

aTYR PHARMA INC

ATYR
$34MMicro Cap

Next catalyst

No upcoming catalyst in our data

No upcoming FDA decision, filing or trial readout is on file for ATYR. That does not mean none is planned.

Get an email about ATYR's next catalysts

Track aTYR PHARMA (ATYR) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Catalyst Timeline

0 upcoming, 2 past

No catalysts found.

Market Overview

Stock performance and key metrics

NASDAQBiological Products, (No Diagnostic Substances)BiotechnologyπŸ‡ΊπŸ‡ΈNorth AmericaSAN DIEGO55 employees

aTyr Pharma is a public biotherapeutics company (Nasdaq: LIFE) that is focused on researching the extracellular functionality and signaling pathways of tRNA synthetases. The company's lead product candidate, ATYR1923, is a selective modulator of Neuropilin-2 (NRP2) that downregulates both the innate and adaptive immune responses in inflammatory disease states. aTyr is developing ATYR1923 as a potential disease-modifying therapy for patients with interstitial lung disease (ILD), a group of rare immune-mediated disorders that cause progressive fibrosis of the lung interstitium and remain a high unmet medical need. ATYR1923 is currently being investigated in a clinical trial in pulmonary sarcoidosis patients.

Website
Drug Pipeline

Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)

Frequently asked questions

What is in aTYR PHARMA INC's drug pipeline?β†’

CatalystAlert tracks 2 drug candidates in aTYR PHARMA INC's (ATYR) pipeline across Phase 3, Phase 2. Its lead program is Efzofitimod (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is aTYR PHARMA INC's next FDA catalyst?β†’

CatalystAlert tracks every upcoming catalyst for aTYR PHARMA INC (ATYR) β€” PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β€” each confidence-rated as confirmed, estimated or AI-detected.

How do I track ATYR biotech catalysts?β†’

Add ATYR to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow aTYR PHARMA INC's live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply